The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Updates in Osteoarthritis: Research Provides Insights into Molecular Pathogenesis of OA

Updates in Osteoarthritis: Research Provides Insights into Molecular Pathogenesis of OA

December 8, 2021 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR Convergence 2021—The session Updates in OA: Distinguishing OA Subtypes & Illuminating Future Therapies at ACR Convergence 2021 featured two presenters. Carla R. Scanzello, MD, PhD, associate professor, Division of Rheumatology, University of Pennsylvania Perelman School of Medicine and rheumatology section chief, Corporal Michael J. Crescenz VA Medical Center, both in Philadelphia, gave a talk titled Understand the Diagnostic Landscape of Osteoarthritis & Defining OA Phenotypes.

You Might Also Like
  • What to Do with Erosive, Inflammatory Osteoarthritis
  • New Clinical Insights into the Pathogenesis, Diagnosis & Treatment of Calcium Pyrophosphate Arthritis
  • Updates in Juvenile Dermatomyositis: Pathogenesis & Patient Care
Explore This Issue
January 2022
Also By This Author
  • A New Frailty Index Aids Lupus Assessment

Dr. Scanzello was followed by Tonia Vincent, MD, PhD, FRCP, professor of musculoskeletal biology at the Kennedy Institute of Rheumatology, University of Oxford, United Kingdom, whose talk was called OA: New Horizons for Therapy.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Phenotypes & Endotypes

Dr. Carla Scanzello

Dr. Scanzello began with noting that consideration of both phenotypes and endotypes is important for the design of clinical trials and for therapeutic development for osteoarthritis (OA).

She reviewed some of the clinical heterogeneity that has led to efforts to define phenotypes of OA. For example, joint involvement can be a single joint or multiple joints. Symptoms can manifest early or late, and progression can happen slowly or rapidly. Bone pathology seen on radiography can be described as atrophic, hypertrophic or erosive.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As researchers try to find associations between these variable phenotypes of OA and prognosis, Gullo et al. found that patients with multi-joint OA had a poorer perception of their health and poorer physical function.1 Others have identified characteristics of knee OA patients with more rapid progression of both pathology and pain.2.3   

Dr. Scanzello also presented research on erosive hand OA to further examine phenotypes. Erosive hand OA is associated with more clinical inflammation, and genetic associations and biomarkers for erosive hand OA may differ from those for non-erosive hand OA. A study from Vanhaverbeke et al. found that erosive changes and clinical swelling were predictive of radiographic progression of hand OA over 10 years, suggesting that this is a more aggressive form of hand OA, Dr. Scanzello said.4

Limitations in OA Research

Dr. Scanzello also shared some of the challenges associated with conducting OA research.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Established criteria used to include patients in OA clinical trials have important limitations, Dr. Scanzello noted. For example, most studies require a grade of 2 on the Kellgren-Lawrence radiographic scale to be included in clinical studies.5 However, recent studies show that those with a grade of 1 also have progression of disease. “The tools that we use to include people in trials are limited in the ability to detect early OA, when patients may be more amenable to treatment,” she said.

Pages: 1 2 3 | Single Page

Filed Under: ACR Convergence, Conditions, Meeting Reports, Osteoarthritis Tagged With: ACR Convergence 2021Issue: January 2022

You Might Also Like:
  • What to Do with Erosive, Inflammatory Osteoarthritis
  • New Clinical Insights into the Pathogenesis, Diagnosis & Treatment of Calcium Pyrophosphate Arthritis
  • Updates in Juvenile Dermatomyositis: Pathogenesis & Patient Care
  • New Research Shows Knee Osteoarthritis Prevalence Is Rising

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)